Literature DB >> 9474689

Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation.

M Duytschaever1, F Haerynck, R Tavernier, L Jordaens.   

Abstract

It is conventionally thought that electrical cardioversion in patients with atrial fibrillation (AF) of longstanding duration or with a large left atrial diameter, only seldom results in long term success. Recurrence is common, although antiarrhythmic drugs often effectively decrease the number and duration of recurrent AF episodes. We analysed clinical, functional and pharmacological variables which could possibly influence the long term outcome after a first electrical cardioversion for AF in a retrospective study on 85 patients. Univariate and multivariate analysis was used to identify factors predicting maintenance of sinus rhythm at 100 days, and absence of recurrence during the entire follow-up. In univariate analysis, the only significant predictor for maintenance of sinus rhythm at 100 days was the duration of the preceding AF episode. Multivariate analysis with persistence of sinus rhythm at 100 days as endpoint confirmed this as a prognostic factor (p < 0.03), but sotalol treatment also contributed to maintenance of sinus rhythm (p < 0.05). When considering the entire observation period, class III antiarrhythmic drugs, i.e. sotalol and amiodarone, were useful in preventing recurrence (p < 0.01 and < 0.02). High age (above 75 years) was a predictor of recurrence. In conclusion, class III antiarrhythmic drugs, the duration of atrial fibrillation and high age were the most important determinants of long term outcome, while echocardiographic parameters and the presence of heart disease played no role.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9474689     DOI: 10.1111/j.1540-8159.1998.tb01105.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

1.  The outcome of direct current cardioversion (DCC) for the treatment of atrial fibrillation (AF) in a district general hospital in Ireland.

Authors:  K P O'Rourke; C Cotter; D Mullane; P Thorpe; P Sullivan
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

2.  Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable?

Authors:  Dariusz A Kosior; Marcin Szulc; Grzegorz Opolski; Adam Torbicki; Daniel Rabczenko
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

3.  The frequency analysis of signal-averaged ECG of P wave as predictor of efficacy of class III antiarrhythmic drugs to maintain sinus rhythm in recurrent idiopathic atrial fibrillation.

Authors:  E C Barbosa; P R Barbosa; P Ginefra; A de Souza Bomfim; S H Boghossian; P J da Rocha; F M Filho
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-01       Impact factor: 1.468

4.  Serological predictors for the recurrence of atrial fibrillation after electrical cardioversion.

Authors:  Sook Kyoung Kim; Hui-Nam Pak; Jae Hyung Park; Kyoung Jeong Ko; Jihei Sara Lee; Jin Wi; Jong Il Choi; Young-Hoon Kim
Journal:  Korean Circ J       Date:  2010-04-22       Impact factor: 3.243

5.  A non-invasive method to predict electrical cardioversion outcome of persistent atrial fibrillation.

Authors:  Raúl Alcaraz; José Joaquín Rieta
Journal:  Med Biol Eng Comput       Date:  2008-04-24       Impact factor: 2.602

6.  Baseline NT-Pro-BNP levels and arrhythmia recurrence in outpatients undergoing elective cardioversion of persistent atrial fibrillation: a survival analysis.

Authors:  Tommaso Sanna; Andrea Sonaglioni; Maurizio Pieroni; Antonio Dello Russo; Gemma Pelargonio; Michela Casella; Evelina Zichichi; Giuseppe La Torre; Maria Lucia Narducci; Fulvio Bellocci
Journal:  Indian Pacing Electrophysiol J       Date:  2009-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.